EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor EC 1.1.1.188 (prostaglandin-F synthase) inhibitor (5Z,13E)-(15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dienoate:NADP(+) 11-oxidoreductase inhibitor (5Z,13E)-(15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dienoate:NADP(+) 11-oxidoreductase inhibitors EC 1.1.1.188 (prostaglandin-F synthase) inhibitor EC 1.1.1.188 (prostaglandin-F synthase) inhibitors EC 1.1.1.188 inhibitor EC 1.1.1.188 inhibitors NADPH-dependent prostaglandin D2 11-keto reductase inhibitor NADPH-dependent prostaglandin D2 11-keto reductase inhibitors PGD2 11-ketoreductase inhibitor PGD2 11-ketoreductase inhibitors PGF synthetase inhibitor PGF synthetase inhibitors PGF2alpha synthetase inhibitor PGF2alpha synthetase inhibitors prostaglandin 11-keto reductase inhibitor prostaglandin 11-keto reductase inhibitors prostaglandin 11-ketoreductase inhibitor prostaglandin 11-ketoreductase inhibitors prostaglandin D2-ketoreductase inhibitor prostaglandin D2-ketoreductase inhibitors prostaglandin F synthase inhibitor prostaglandin F synthase inhibitors prostaglandin F synthetase inhibitor prostaglandin F synthetase inhibitors prostaglandin-D2 11-reductase inhibitor prostaglandin-D2 11-reductase inhibitors reductase, 15-hydroxy-11-oxoprostaglandin inhibitor reductase, 15-hydroxy-11-oxoprostaglandin inhibitors synthetase, prostaglandin F2alpha inhibitor synthetase, prostaglandin F2alpha inhibitors